News|Articles|June 2, 2001
- Pharmaceutical Technology-06-02-2001
- Volume 25
- Issue 6
Viral Clearance Strategies for Biopharmaceutical Safety
Special considerations and cautions must be adhered to when designing virus safety studies and developing appropriate virus contamination control programs.
Advertisement
Articles in this issue
about 25 years ago
Outsourcing Outlookabout 25 years ago
Managing Risks and Resourcesabout 25 years ago
Blister News: COC Resin, Foil, and Lidding Innovationsabout 25 years ago
Managing the Risks in Outsourcingabout 25 years ago
Systemic Drug Delivery via the Buccal Mucosal RouteAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FDA Duloxetine Recall Highlights Generic Manufacturing Quality Gaps
2
Germany Pharma Tariff Threat: What Manufacturers Need to Know
3
Why the First Generic Single-Dose Flu Antiviral Approval Matters
4
PharmTech Weekly Roundup—June 19, 2026
5